- Home
- Publications
- Publication Search
- Publication Details
Title
New P2Y
12
Inhibitors
Authors
Keywords
-
Journal
CIRCULATION
Volume 121, Issue 1, Pages 171-179
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-01-05
DOI
10.1161/circulationaha.109.853069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2009) Stefan James et al. AMERICAN HEART JOURNAL
- Drug–Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors
- (2009) Nicholas B Norgard et al. ANNALS OF PHARMACOTHERAPY
- Can We Override Clopidogrel Resistance?
- (2009) Ana Pena et al. CIRCULATION
- Bedside Evaluation of Thienopyridine Antiplatelet Therapy
- (2009) Matthew J. Price CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- The P2Y12Antagonists, 2-Methylthioadenosine 5′-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP Levels
- (2009) Subhashini Srinivasan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38
- (2009) Rebecca E. Wrishko et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- (2009) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
- (2008) Laurent Bonello et al. AMERICAN JOURNAL OF CARDIOLOGY
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
- (2008) S. A. Murphy et al. EUROPEAN HEART JOURNAL
- Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance
- (2008) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The reversible P2Y12antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function
- (2008) N. L. DOVLATOVA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Approaching an age of reason with antiplatelet therapy
- (2008) Andrew E Ajani et al. LANCET
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
- (2008) Stephen D Wiviott et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prasugrel development – Claims and achievements
- (2008) Inna Shalito et al. THROMBOSIS AND HAEMOSTASIS
- Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
- (2007) Steven R. Steinhubl et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search